Email
Password
Remember meForgot password?
    Log in with Twitter

study halted by NIH News

Eli Lilly's antibody drug for COVID-19 patients fails in study

By Karen Graham
Late on Monday, the National Institute of Allergy and Infectious Diseases (NIAID), ended a study into the effectiveness of Eli Lilly's antibody treatment for hospitalized COVID-19 patients due to a lack of effectiveness.
 

Search Digital Journal Archives


Set up a news alert for

study halted by NIH


study halted by NIH Image
Latest News
Top News
Foreign forces ignore Libya exit deadline under fragile truce
Chuck Schumer: New US Senate leader faces trial by fire
Saudi intercepts 'hostile target' over capital
Trump mulled replacing attorney general over election results: US media
Cyprus rocked by sexual assault claims of Olympic shooter
Endangered Siamese crocodile in rare sighting at Thai national park
Afghan officials welcome Biden plan to review US-Taliban deal
Biden administration to review US-Taliban withdrawal deal
New warning on vaccine supplies sparks EU concern
Review: Olivia Newton-John, Chloe Lattanzi stun in 'Window in the Wall' Special